Sun Pharma's Long-Term Bank Facility Rating Reaffirmed by CRISIL at AAA/Stable
Sun Pharmaceutical Industries Ltd has seen its long-term bank facility rating reaffirmed by CRISIL Ratings Limited. The rating reassessment confirmed the stability of the company's financial standing, removing a previously noted cautious status.CRISIL Ratings Limited has officially removed the 'Rating Watch with Developing Implications' status assigned to Sun Pharmaceutical Industries Limited’s long-term bank facilities. This decision comes following the Company's prior announcement made on April 27, 2026, which prompted the initial review.
The ratings agency has now reaffirmed the rating for the company's long-term bank facilities at 'CRISIL AAA/Stable'.
This updated status signifies a positive movement in the credit assessment of Sun Pharmaceutical Industries Ltd by CRISIL Ratings Limited.
SUNPHARMA Stock Price Movement
As of 9:22 AM, shares of Sun Pharmaceutical Industries Limited are slipping in live trading, currently hovering at ₹1948.3 after shedding 0.80%.The stock sees a volume tallying 50,059 as it trades against the backdrop of the market morning.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.